| pubmed-article:49200 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:49200 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:49200 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:49200 | lifeskim:mentions | umls-concept:C0041249 | lld:lifeskim |
| pubmed-article:49200 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:49200 | lifeskim:mentions | umls-concept:C0444706 | lld:lifeskim |
| pubmed-article:49200 | lifeskim:mentions | umls-concept:C0243144 | lld:lifeskim |
| pubmed-article:49200 | lifeskim:mentions | umls-concept:C2349101 | lld:lifeskim |
| pubmed-article:49200 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:49200 | pubmed:dateCreated | 1975-10-10 | lld:pubmed |
| pubmed-article:49200 | pubmed:abstractText | The uptake of L-tryptophan by chicken erythrocytes is stimulated by the presence of human plasma; however, there is no difference between the stimulation caused by plasmas of normal, chronic hospitalized nonschizophrenic, or chronic hospitalized schizophrenic subjects. Human plasma in general contains a complement-dependent antibody which reacts with an antigen present in the membrane of chicken erythrocytes resulting in hemolysis. Hemolysis can be maintained at a constant level by certain concentrations of Ca++ ion, the addition of which resulted in a gradual increase in tryptophan uptake. The calcium effect is probably due to the fact that the metal acts as a cofactor or modifier of component(s) of plasma causing higher uptake. The data indicate that hemolysis is not determining uptake of tryptophan by chicken erythrocytes. | lld:pubmed |
| pubmed-article:49200 | pubmed:language | eng | lld:pubmed |
| pubmed-article:49200 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:49200 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:49200 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:49200 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:49200 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:49200 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:49200 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:49200 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:49200 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:49200 | pubmed:issn | 0006-3223 | lld:pubmed |
| pubmed-article:49200 | pubmed:author | pubmed-author:PriceW HWH | lld:pubmed |
| pubmed-article:49200 | pubmed:author | pubmed-author:GuchhaitR BRB | lld:pubmed |
| pubmed-article:49200 | pubmed:author | pubmed-author:JansonCC | lld:pubmed |
| pubmed-article:49200 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:49200 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:49200 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:49200 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:49200 | pubmed:pagination | 303-14 | lld:pubmed |
| pubmed-article:49200 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Hu... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-An... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Sc... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Me... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Er... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Ca... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-He... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Te... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Gu... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Ag... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Pl... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Tr... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Co... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Ma... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Ed... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Mi... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Ch... | lld:pubmed |
| pubmed-article:49200 | pubmed:meshHeading | pubmed-meshheading:49200-Al... | lld:pubmed |
| pubmed-article:49200 | pubmed:year | 1975 | lld:pubmed |
| pubmed-article:49200 | pubmed:articleTitle | Validity of plasma factor in schizophrenia as measured by tryptophan uptake. | lld:pubmed |
| pubmed-article:49200 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:49200 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
